Evaluation of coronary artery disease by computed tomography angiography in patients treated for Hodgkin lymphoma

Asia-Pacific Journal of Oncology and Hematology

Volumn 2, Issue 2, 2010, Pages

  Küpeli, Serhan ^a  

^a Diyarbakir Children's Diseases Hospital   (Turkey)

Author keywords

Cardiotoxicity; Children; Computed tomography angiography; Coronary artery disease; Hodgkin lymphoma; Survivors

Indexed keywords

ALKYLATING AGENT; ANTHRACYCLINE; BLEOMYCIN; CALCIUM; CHLORMETHINE; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; IODINATED CONTRAST MEDIUM; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCA ALKALOID; VINCRISTINE;

ALOPECIA; ARTERITIS; BLOOD VESSEL OCCLUSION; BONE DISEASE; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CARDIOMYOPATHY; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONGESTIVE HEART FAILURE; CONSTRICTIVE PERICARDITIS; CORONARY ARTERY DISEASE; EARLY DIAGNOSIS; ENDOCRINE DISEASE; HEART ARRHYTHMIA; HEART CATHETERIZATION; HEART INFARCTION; HODGKIN DISEASE; HUMAN; INFECTION; LUNG FIBROSIS; LUNG TOXICITY; MINIMALLY INVASIVE PROCEDURE; NAUSEA AND VOMITING; NEUROTOXICITY; PERICARDIAL EFFUSION; RADIATION DOSE; RADIATION EXPOSURE; RADIATION PNEUMONIA; RADIATION RESPONSE; REVIEW; RISK ASSESSMENT; SOFT TISSUE DEFECT; SPONTANEOUS PNEUMOTHORAX;

EID: 79951570022     PISSN: 17596637     EISSN: 17596645     Source Type: Journal    
DOI: None     Document Type: Review

References (102)

1. Prokop M. Multislice CT angiography. Eur J Radiol. 2000;36:86-96.
2. Schoepf UJ, Becker CR, Hofmann LK, et al. Multislice CT angiography. Eur Radiol. 2003;13:1946-1961.
3. Computed tomography angiography (CTA). RadiologyInfo. http://www.radiologyinfo.org/, January 18, 2006.
4. Wilson GT, Gopalakrishnan P, Tak T. Noninvasive cardiac imaging with computed tomography. Clin Med Res. 2007;5:165-171.
5. Hoffmann MH, Shi H, Schmitz BL, et al. Noninvasive coronary angiography with multislice computed tomography. JAMA. 2005;293: 2471-2478.
6. Hazirolan T. Koroner arterlerin çok dedektörlü bilgisayarli tomografi ile görüntülenmesi. Hacettepe Tip Dergisi. 2006;37:6-13.
7. Akin O, Coşkun M. Multi-detector CT angiography: technique and clinical applications. Tani Girisim Radyol. 2003;9:139-145.
8. Nishino M, Kubo T, Kataoka ML, et al. Evaluation of thoracic abnormalities on 64-row multi-detector row CT: comparison between axial images versus coronal reformations. Eur J Radiol. 2006;59:33-41.
9. Bohme E, Steinbigler P, Czernik A, et al. Invasive versus noninvasive (MSCT) coronary angiography. Importance of cardiac diagnostics with multislice computed tomography. Herz. 2003;28:36-43.
10. Cohen RA, Frush DP, Donnelly LF. Data acquisition for pediatric CT angiography: problems and solutions. Pediat Radiol. 2000;30:813-822.
11. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990's. Nature. 1993;362:801-809.
12. O'Rourke R, Brundage B, Froelicher V, et al. ACC/AHA expert consensus document on electron beam CT for the diagnosis and prognosis of coronary artery disease. Circulation. 2000;102:126-140.
13. Achenbach S, Ropers D, Pohle K, et al. Influence of lipid lowering therapy on the progression of coronary artery calcification: a prospective evaluation. Circulation. 2002;106:1077-1082.
14. Mollet NR, Cademartiri F, Nieman K, et al. Multislice spiral computed tomography coronary angiography in patients with stable angina pectoris. J Am Coll Cardiol. 2004;43:2265-2270.
15. Revel MP, Petrover D, Hernigou A, et al. Diagnosing pulmonary embolism with four-detector row helical CT: prospective evaluation of 216 outpatients and inpatients. Radiology. 2005;234:265-273.
16. Schoepf UJ. Pulmonary artery CTA. Tech Vasc Interv Radiol. 2006;9:180-191.
17. Glockner JF, Vrtiska TJ. Renal MR and CT angiography: current concepts. Abdom Imaging. 2007;32(3):407-420.
18. Rountas C, Vlychou M, Vassiou K, et al. Imaging modalities for renal artery stenosis in suspected renovascular hypertension: prospective intraindividual comparison of color Doppler US, CT angiography, GDenhanced MR angiography, and digital substraction angiography. Ren Fail. 2007;29(3):295-302.
19. Hofmann LK, Zou KH, Costello P, Schoepf UJ. Electrocardiographically gated 16-section CT of the thorax: cardiac motion suppression. Radiology. 2004;233:927-933.
20. Hayter RG, Rhea JT, Small A, et al. Suspected aortic dissection and other aortic disorders: multi-detector row CT in 373 cases in the emergency setting. Radiology. 2006;238:841-852.
21. Theisen D, von Tengg-Kobligk H, Michaely H, et al. CT angiography of the aorta. Radiologe. 2007;47(11):982-992.
22. Samyn MM. A review of the complementary information available with cardiac MRI and multi-slice CT during the study of congenital heart disease. Int J Cardiovasc Imaging. 2004;20:569-578.
23. Hopkins KL, Patrick LE, Simoneaux SF, et al. Pediatric great vessel anomalies: initial clinical experience with spiral CT angiography. Radiology. 1996;200:811-815.
24. Walsh M, Adams WM, Mukonoweshuro W. CT angiography of intracranial aneurysms related to arteriovenous malformations: a cautionary tale. Neuroradiology. 2006;48:255-258.
25. Gazzola S, Aviv RI, Gladstone DJ, Mallia G, Li V, Fox AJ, Symons SP. Vascular and nonvascular mimics of the CT angiography ''spot sign'' in patients with secondary intracerebral hemorrhage. Stroke. 2008;39:1177-1183.
26. Coenen VA, Dammert S, Reinges MH, Mull M, Gilsbach JM, Rohde V. Image-guided microneurosurgical management of small cerebral arteriovenous malformations: the value of navigated computed tomographic angiography. Neuroradiology. 2005;47:66-72.
27. Vassilyadi M, Jones BV, Ball WS Jr. Identification of an arteriovenous fistula in a child. Case report and review of the literature. Childs Nerv Syst. 2001;17:685-688.
28. Schellinger PD, Richter G, Kohrmann M, Dorfler A. Noninvasive angiography (magnetic resonance and computed tomography) in the diagnosis of ischemic cerebrovascular disease. Techniques and clinical applications. Cerebrovasc Dis. 2007;24(suppl 1):16-23.
29. Lawler LP, Fishman EK. Multidetector row computed tomography of the aorta and peripheral arteries. Cardiol Clin. 2003;21:607-629.
30. Fleishman D, Lammer J. Peripheral CT angiography for interventional treatment planning. Eur Radiol. 2006;16(suppl 7):M58-M64.
31. Blum MB, Schmook M, Schernthaner R, et al. Quantification and detectability of in-stent stenosis with CT angiography and MR angiography in arterial stents in vitro. AJR Am J Roentgenol. 2007;189: 1238-1242.
32. Gaspar T, Halon D, Rubinshtein R, Peled N. Clinical applications and future trends in cardiac CTA. Eur Radiol. 2000;15(suppl 4):D10-D14.
33. Brietzke SE, Jones DT. Pediatric oropharyngeal trauma: what is the role of CT scan? Int J Pediatr Otorhinolaryngol. 2005;69:669-679.
34. Kumano S, Tsuda T, Tanaka H, et al. Preoperative evaluation of perigastric vascular anatomy by 3-dimensional computed tomographic angiography using 16-channel multidetector-row computed tomography for laparoscopic gastrectomy in patients with early gastric cancer. J Comput Assist Tomogr. 2007;3:93-97.
35. Toprak U, Erdoǧan A, Gülbay M, et al. Preoperative evaluation of renal anatomy and renal masses with helical CT, 3D-CT and 3D-CT angiography. Diagn Interv Radiol. 2005;11:35-40.
36. Srivastava DN. Imaging and therapeutic interventions in hepatic tumours. Trop Gastroenterol. 2000;21:103-113.
37. Bittles MA, Sidhu MK, Sze RW, et al. Multidetector CT angiography of pediatric vascular malformations and hemangiomas: utility of 3-D reformatting in differential diagnosis. Pediatr Radiol. 2005;35:1100-1106.
38. Zimmet JM, Miller JM. Coronary artery CTA: imaging of atherosclerosis in the coronary arteries and reporting coronary artery CTA findings. Tech Vasc Interventional Rad. 2006;9:218-226.
39. Küpeli S, Varan A, Hazirolan T, Büyükpamukçu M. Malignant coronary artery anomaly in a survivor of Hodgkin's lymphoma. Pediatr Cardiol. 2010;31(4):569-570.
40. Ehara M, Surmely JF, Kawai M, et al. Diagnostic accuracy of 64-slice computed tomography for detecting angiographically significant coronary artery stenosis in an unselected consecutive patient population: comparison with conventional invasive angiography. Circ J. 2006; 70:564-571.
41. Hudson MM, Onciu M, Donaldson SS. Hodgkin lymphoma. In: Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology. Philadelphia, PA: Lippincot Williams and Wilkins; 2006:695-721.
42. Arya LS, Dinand V, Thavaraj V, et al. Hodgkin's disease in Indian children: Outcome with chemotherapy alone. Pediatr Blood Cancer. 2006; 46:26-34.
43. Kung FH, Schwartz CL, Ferree CR, et al. POG 8625: a randomized trial comparing chemotherapy with chemoradiotherapy for children and adolescents with stages I, IIA, IIIA1 Hodgkin disease: a report from the children's oncology group. J Pediatr Hematol Oncol. 2006;28:362-368.
44. Hodgson DC. Hodgkin lymphoma: the follow-up of long term survivors. Hematol Oncol Clin N Am. 2008;22:233-244.
45. Claviez A, Klingebiel T, Beyer J, et al. Allogeneic peripheral blood stem cell transplantation following fludarabine-based conditioning in six children with advanced Hodgkin's disease. Ann Hematol. 2004;83:237-241.
46. Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer. N Eng J Med. 2006;355:1572-1582.
47. Moser EC, Noordijk EM, van Leeuwen FE, et al. Long-term risk of cardiovascular disease after treatment for aggressive non-Hodgkin lymphoma. Blood. 2006;107:2912-2919.
48. Hoppe RT. Hodgkin's disease: complications of therapy and excess mortality. Ann Oncol. 1997;8(suppl 1):115-118.
49. Ng AK, Bernardo MP, Weller E, et al. Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger. J Clin Oncol. 2002;20:2101-2108.
50. Swerdlow AJ, Higgins CD, Smith P, et al. Myocardial infarction mortality risk after treatment for Hodgkin disease: a collaborative British cohort study. J Natl Cancer Inst. 2007;99:206-214.
51. Aleman BMP, van den Belt-Dusebout AW, Klokman WJ, van't Veer MB, Bartelink H, van Leeuwen FE. Long-term cause-specific mortality of patients treated for Hodgkin's disease. J Clin Oncol. 2003;21:3431-3439.
52. Hancock SL, Tucker MA, Hoppe RT. Factors affecting late mortality from heart disease after treatment of Hodgkin's disease. J Am Med Assoc. 1993;270:1949-1955.
53. Wu S, Ko YS, Teng MS, et al. Adriamycin-induced cardiomyocyte and endothelial cell apoptosis: in vitro and in vivo studies. J Mol Cell Cardiol. 2002;34:1595-1607.
54. Kismet E, Varan A, Ayabakan C, et al. Serum troponin-t levels and echocardiographic evaluation in children treated with doxorubicin. Pediatr Blood Cancer. 2004;42:220-224.
55. Avilés A, Neri N, Nambo JM, et al. Late cardiac toxicity secondary to treatment in Hodgkin's disease. A study comparing doxorubicin, epirubicin and mitoxantrone in combined therapy. Leuk Lymphoma. 2005;46:1023-1028.
56. Glanzmann C, Kaufmann P, Jenni R, Hess OM, Huguenin P. Cardiac risk after mediastinal irradiation for Hodgkin's disease. Radiother Oncol. 1998;46:51-62.
57. Giantris A, Abdurrahman L, Hinkle A, Asselin B, Lipshultz SE. Anthracycline-induced cardiotoxicity in children and young adults. Crit Rev Oncol Hematol. 1998;27:53-68.
58. King V, Constine LS, Clark D, et al. Symptomatic coronary artery disease after mantle irradiation for Hodgkin's disease. Int J Radiat Oncol Biol Phys. 1996;36:881-889.
59. Hancock SL, Donaldson SS, Hoppe RT. Cardiac disease following treatment of Hodgkin's disease in children and adolescents. J Clin Oncol. 1993;11:1208-1215.
60. House KW, Simon SR, Pugh RP. Chemotherapy-induced myocardial infarction in a young man with Hodgkin's disease. Clin Cardiol. 1992;15:122-125.
61. Scholz KH, Herrmann C, Tebbe U, et al. Myocardial infarction in young patients with Hodgkin's disease*potential pathogenic role of radiotherapy, chemotherapy, and splenectomy. Clin Investig. 1993;71:57-64.
62. Fajardo LF. Acta oncologica lecture. The pathology of ionizing radiation as defined by morphologic patterns. Acta Oncologica. 2005;44:13-22.
63. Fajardo LF, Berthrong M. Vascular lesions following radiation. Pathol Annu. 1988;23:297-330.
64. Sciubba DM, Gallia GL, Recinos P, Garonzik IM, Clatterbuck RE. Intracranial aneurysm following radiation therapy during childhood for a brain tumor. Case report and review of the literature. J Neurosurg. 2006;105(suppl 2):134-139.
65. Aoki S, Hayashi N, Abe O, et al. Radiation induced arteritis: thickened wall with prominent enhancement on cranial MR images*report of five cases and comparison with 18 cases of Moyamoya disease. Radiology. 2002;223:683-688.
66. Hull MC, Morris CG, Pepine CJ, Mendenhall NP. Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of Hodgkin lymphoma treated with radiation therapy. JAMA. 2003;290: 2831-2837.
67. Heidenreich PA, Hancock SL, Lee BK, et al. Asymptomatic cardiac disease following mediastinal irradiation. J Am Coll Cardiol. 2003;42:743-749.
68. Heidenreich PA, Hancock SL, Vagelos RH, et al. Diastolic dysfunction after mediastinal irradiation. Am Heart J. 2005;150:977-982.
69. Heidenreich PA, Schnittger I, Strauss HW, et al. Screening for coronary artery disease after mediastinal irradiation for Hodgkin's disease. J Clin Oncol. 2007;25:43-49.
70. Hennekens CH. Risk factors for coronary heart disease in women. Cardiol Clinics. 1998;16:1-8.
71. Thom TJ. International mortality from heart disease: rates and trends. Int J Epidemiol. 1989;18:20-28.
72. Onat A, Şurdum-Avci G, Şenocak M, et al. Türkiye'de Erişkinlerde Kalp Hastaliǧi ve Risk Faktö rleri Sikliǧ i Taramasi: 3. Kalp Hastaliklari Prevalansi. Türk Kardiyoloji Derneǧi Arşivi. 1991;19:26-33.
73. Onat A, Dursunoǧlu D, Sansoy V. Relatively high coronary death and event rates in Turkish women: relation to three major risk factors in five-year follow-up cohort. Int J Cardiol. 1997;61:69-77.
74. Brezinka V, Padmos I. Coronary heart risk factors in women. Eur Heart J. 1994;15:1571-1584.
75. Aksoy L, Küpeli S, Kasim AB, et al. Prevalence of coronary heart disease risk factors among women in Köstence, Ankara. Turk J Med Sci. 2002;32: 403-407.
76. Jones PH, Gotto AM. Prevention of coronary heart disease in 1994 evidence for intervention. Heart Dis Stroke. 1994;3:290-296.
77. Amery A, Birkenhager W, Brixko P, et al. Mortality and morbidity results from the European working party on high blood pressure in the elderly. Lancet. 1985;1:1349-1354.
78. Neaton JD, Wentworth D. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Arch Intern Med. 1992;152: 56-64.
79. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the systolic hypertension in the elderly program (SHEP). JAMA. 1991;265:3255-3264.
80. Staessen JA, Fagard R, Thijs L, et al. Morbidity and mortality in the placebo-controlled European trial on isolated systolic hypertension in the elderly. Lancet. 1997;350:757-764.
81. James PT, Rigby N, Leach R. International obesity task force. The obesity epidemic, metabolic syndrome and future prevention strategies. Eur J Cardiovasc Prev Rehabil. 2004;11:3-8.
82. Adams KF, Schatzkin A, Harris TB, Kipnis V, Mouw T, Ballard-Barbash R, Hollenbeck A, Leitzmann MF. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N. Engl. J. Med. 2006;355:763-778.
83. Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, Kannel WB, Vasan RS. Obesity and the risk of heart failure. N. Engl. J. Med. 2002;347:305-313.
84. Olshansky SJ, Passaro DJ, Hershow RC, Layden J, Carnes BA, Brody J, Hayflick L, Butler RN, Allison DB, Ludwig DS. A potential decline in life expectancy in the United States in the 21st century. N. Engl. J. Med. 2005;352:1138-1145.
85. Eckel RH, Kahn R, Robertson RM, Rizza RA. Preventing cardiovascular disease and diabetes. A call to action from the American Diabetes Association and the American Heart Association. Circulation. 2006;113: 2943-2946.
86. Karalis DG. Intensive lowering of low-density lipoprotein cholesterol levels for primary prevention of coronary artery disease. Mayo Clin Proc. 2009;84:345-352.
87. Briel M, Ferreira-Gonzalez I, You JJ, et al. Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis. BMJ. 2009;16:338.
88. S. Emerging strategies and agents to lower cardiovascular risk by increasing high density lipoprotein cholesterol levels. Curr Med Chem. 2009;16:144-156.
89. Iso H. Changes in coronary heart disease risk among Japanese. Circulation. 2008;118:2725-2729.
90. Barthelemy O, Jacqueminet S, Rouzet F, et al. Intensive cardiovascular risk factors therapy and prevalence of silent myocardial ischaemia in patients with type 2 diabetes. Arch Cardiovasc Dis. 2008;101:539-546.
91. Bell DS. Diabetes: a cardiac condition manifesting as hyperglycemia. Endocr Pract. 2008;14:924-932.
92. Anselmino M, Wallander M, Norhammar A, Mellbin L, Rydén L. Implications of abnormal glucose metabolism in patients with coronary artery disease. Diab Vasc Dis Res. 2008;5:285-290.
93. Csiszar A, Podlutsky A, Wolin MS, Losonczy G, Pacher P, Ungvari Z. Oxidative stress and accelerated vascular aging: implications for cigarette smoking. Front Biosci. 2009;14:3128-3144.
94. Reid C, Nelson MR, Shiel L, Chew D, Connor G, DeLooze F. Australians at risk: management of cardiovascular risk factors in the REACH Registry. Heart Lung Circ. 2008;17:114-118.
95. Al-Sarraf N, Thalib L, Hughes A, Tolan M, Young V, McGovern E. Effect of smoking on short-term outcome of patients undergoing coronary artery bypass surgery. Ann Thorac Surg. 2008;86:517-523.
96. Mayer B, Erdmann J, Schunkert H. Genetics and heritability of coronary artery disease and myocardial infarction. Clin Res Cardiol. 2007;96:1-7.
97. Jaumdally JR, Lip GY, Varma C. Traditional risk factors for coronary atherosclerosis in Indo Asians: the need for a reappraisal. Curr Pharm Des. 2006;12:1611-1621.
98. Roberts R, Stewart AF. Personalized genomic medicine: a future prerequisite for the prevention of coronary artery disease. Am Heart Hosp J. 2006;4:222-227.
99. Watkins H, Farrall M. Genetic susceptibility to coronary artery disease: from promise to progress. Nat Rev Genet. 2006;7:163-173.
100. Crouch MA, Gramling R. Family history of coronary heart disease: evidence-based applications. Prim Care. 2005;32:995-1010.
101. Rademaker J, Schöder H, Ariaratnam NS, et al. Coronary artery disease after radiation therapy for Hodgkin's lymphoma: coronary CT angiography findings and calcium scores in nine asymptomatic patients. Am J Roentgenol. 2008;191:32-37.
102. Küpeli S, Hazirolan T, Varan A, et al. Evaluation of coronary artery disease by computed tomography angiography in patients treated for childhood Hodgkin's lymphoma. J Clin Oncol. 2010;28:1025-1030.